Evidence map›Paper›PMID 26090086›Full record

ArticleJournal of tissue engineering2015

Alginate hydrogel enriched with enamel matrix derivative to target osteogenic cell differentiation in TiO2 scaffolds.

Helen Pullisaar, Anders Verket, Krisztina Szoke, Hanna Tiainen, Håvard J Haugen, Jan E Brinchmann, Janne E Reseland, Esben Østrup

Abstract read
In one paragraph

Article in Journal of tissue engineering, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Helen PullisaarDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.
Anders VerketDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.
Krisztina SzokeInstitute of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Hanna TiainenDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.
Håvard J HaugenDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.
Jan E BrinchmannInstitute of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway ; Norwegian Center for Stem Cell Research, Department of Biochemistry, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Janne E ReselandDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.
Esben ØstrupDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway ; Norwegian Center for Stem Cell Research, Department of Biochemistry, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of bone tissue engineering is to employ scaffolds, cells, and growth factors to facilitate healing of bone defects. The aim of this study was to assess the viability and osteogenic differentiation of primary human osteoblasts and adipose tissue-derived mesenchymal stem cells from various donors on titanium dioxide (TiO2) scaffolds coated with an alginate hydrogel enriched with enamel matrix derivative. Cells were harvested for quantitative reverse transcription polymerase chain reaction on days 14 and 21, and medium was collected on days 2, 14, and 21 for protein analyses. Neither coating with alginate hydrogel nor alginate hydrogel enriched with enamel matrix derivative induced a cytotoxic response. Enamel matrix derivative-enriched alginate hydrogel significantly increased the expression of osteoblast markers COL1A1, TNFRSF11B, and BGLAP and secretion of osteopontin in human osteoblasts, whereas osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells seemed unaffected by enamel matrix derivative. The alginate hydrogel coating procedure may have potential for local delivery of enamel matrix derivative and other stimulatory factors for use in bone tissue engineering.

Indexed as

alginate hydrogelEnamel matrix derivativehuman adipose tissue–derived mesenchymal stem cellsprimary human osteoblastsTiO2 scaffold

Identifiers

PMID26090086
PMCPMC4456326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.